Literature DB >> 3117103

Different types of microheterogeneity of human thyroxine-binding prealbumin.

T Pettersson1, A Carlström, H Jörnvall.   

Abstract

Human thyroxine-binding prealbumin or transthyretin has been isolated by three different methods. In all cases, the isolated material is microheterogeneous in an isoelectric focusing system, revealing a pattern of at least 10 bands. These subforms represent tetramers. Dissociation of the protein in serum samples and dissociation in the presence of urea or sodium dodecyl sulfate (SDS) reveal eight other forms, differing in isoelectric point and concluded to be monomers. Two different sets of dissociated forms are identified, one from urea treatment and the other from SDS treatment. The latter set is apparently also present in serum. Interpretations are complicated by multiplicities of all forms, atypical electrophoretic migrations, nonidentical effects of urea and SDS, and the absence of dimer under most conditions. However, reassociations of monomers and formation of interspecies hybrid molecules identify dimers and clarify interpretations of the dissociated sets. In at least five of the forms likely to represent monomers, the difference is dependent on the nature of the SH group at Cys-10, which can be oxidized, can be reduced, or can be in a mixed disulfide, probably with glutathione and its degradation products. Amino acid sequence analysis reveals an additional N-terminal heterogeneity (with start at positions 1, 2, and 3) of the three most abundant monomers, but this does not explain the observed differences among monomeric forms. It is concluded that prealbumin exhibits different types of microheterogeneity, the major pattern of which is explained by the status of the subunit SH group and the ability of prealbumin to dissociate into monomers. A relation appears to exist between SH group status on the one hand, and retinol-binding protein interaction, the ability to dissociate into monomers, and possibly also binding of thyroxine on the other. These interactions suggest complex functional relationships for prealbumin in serum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117103     DOI: 10.1021/bi00388a061

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Human class III alcohol dehydrogenase/glutathione-dependent formaldehyde dehydrogenase.

Authors:  R Kaiser; B Holmquist; B L Vallee; H Jörnvall
Journal:  J Protein Chem       Date:  1991-02

2.  Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling.

Authors:  Essam Refai; Nancy Dekki; Shao-Nian Yang; Gabriela Imreh; Over Cabrera; Lina Yu; Guang Yang; Svante Norgren; Sophia M Rössner; Luca Inverardi; Camillo Ricordi; Gunilla Olivecrona; Mats Andersson; Hans Jörnvall; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

3.  Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans.

Authors:  Liwei Chen; Xixuan Hu Collins; Louisa B Tabatabai; Wendy S White
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

4.  Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics.

Authors:  S B Jensen; K Hindberg; T Solomon; E N Smith; J D Lapek; D J Gonzalez; N Latysheva; K A Frazer; S K Braekkan; J-B Hansen
Journal:  J Thromb Haemost       Date:  2018-08-06       Impact factor: 5.824

5.  Post-translational modifications of transthyretin affect the triiodonine-binding potential.

Authors:  Andrea Henze; Thomas Homann; Mustafa Serteser; Ozge Can; Ozlem Sezgin; Abdurrahman Coskun; Ibrahim Unsal; Florian J Schweigert; Aysel Ozpinar
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

6.  Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Keld Poulsen; Justyna Mc Bahl; Anja H Simonsen; Steen G Hasselbalch; Niels Hh Heegaard
Journal:  Clin Proteomics       Date:  2014-03-29       Impact factor: 3.988

7.  Delineation of concentration ranges and longitudinal changes of human plasma protein variants.

Authors:  Olgica Trenchevska; David A Phillips; Randall W Nelson; Dobrin Nedelkov
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 8.  The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.

Authors:  Chiara Sanguinetti; Marianna Minniti; Vanessa Susini; Laura Caponi; Giorgia Panichella; Vincenzo Castiglione; Alberto Aimo; Michele Emdin; Giuseppe Vergaro; Maria Franzini
Journal:  Biomedicines       Date:  2022-08-06

9.  Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.

Authors:  C Thylén; J Wahlqvist; E Haettner; O Sandgren; G Holmgren; E Lundgren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

10.  Is Transthyretin a Regulator of Ubc9 SUMOylation?

Authors:  Elżbieta Wieczorek; Sylwia Kędracka-Krok; Katarzyna Sołtys; Urszula Jankowska; Rafał Hołubowicz; Justyna Seliga; Andrzej Ożyhar
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.